P O Livingston

Vaccines containing purified GM2 ganglioside elicit GM2 antibodies in melanoma patients.

P O Livingston, Edward J. Natoli, M J Calves et al. · Proceedings of the National Academy of Sciences · 1987 · 222 citations · Full text

Immunoediting, Immunology, Pathology +17

GD3 vaccines for melanoma: superior immunogenicity of keyhole limpet hemocyanin conjugate vaccines.

Friedhelm Helling, A Shang, M J Calves et al. · PubMed · 1994 · 179 citations

Immunology, Immunoediting, Pathology +19

Cell-surface antigens of melanoma recognized by human monoclonal antibodies.

Hiroshi Yamaguchi, K. Furukawa, Sheila R. Fortunato et al. · Proceedings of the National Academy of Sciences · 1987 · 105 citations · Full text

Tumor Immunology, Cancer Immunosurveillance, Epstein-barr Virus +14

Antibodies against GD2 ganglioside can eradicate syngeneic cancer micrometastases.

Hongjie Zhang, Shengle Zhang, N K Cheung et al. · PubMed · 1998 · 101 citations

Cancer Immunosurveillance, Malignant Disease, Gd2 Ganglioside +15

Approaches to augmenting the immunogenicity of the ganglioside GM2 in mice: purified GM2 is superior to whole cells.

P O Livingston, M J Calves, Edward J. Natoli · The Journal of Immunology · 1987 · 67 citations

Ganglioside Gm2, Immunology, Immunologic Mechanism +19